The lowest BARX2 expression was observed in acute myeloid leukaemia (LAML), pheochromocytoma and paraganglioma (PCPG), and uveal melanoma (UVM), and BARX2 expression in LIHC was at a moderate to low. This evidence concerns the gene BARX2 and pheochromocytoma.